---
schema_version: "secwatch.filing_event.v1"
accession: "0000078003-24-000130"
form_type: "8-K"
ticker: "PFE"
cik: "0000078003"
company_name: "PFIZER INC"
filed_at: "2024-07-10T23:59:59+00:00"
generated_at: "2026-05-31T22:21:33.028319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pfizer begins external search for successor to Chief Scientific Officer Mikael Dolsten

## Summary
- CSO and President of R&D Mikael Dolsten to step down after over 15 years; external search launched.
- Dr. Dolsten will stay in current role until successor is appointed, at least through Feb 28, 2025.
- No successor named; transition process formally announced on July 9, 2024.

## SEC filing metadata
- accession: 0000078003-24-000130
- form_type: 8-K
- ticker: PFE
- cik: 0000078003
- company_name: PFIZER INC
- filed_at: 2024-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/0000078003-24-000130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/pfe-20240709.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000078003-24-000130
- JSON: https://secwatch.observer/filing/0000078003-24-000130.json
- Plain text: https://secwatch.observer/filing/0000078003-24-000130.txt

## Key facts
- Executive change
  Mikael Dolsten departed as Chief Scientific Officer and President, Pfizer Research & Development at PFIZER INC.
  - Role: Chief Scientific Officer and President, Pfizer Research & Development
  source text: On July 9, 2024, Pfizer Inc. (the "Company") announced that it is beginning the process of finding a successor for Dr. Mikael Dolsten, the Company’s Chief Scientific Officer and President, Pfizer Research & Development after his more than 15-year distinguished career with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/0000078003-24-000130-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.